MONTGOMERY, Texas--(BUSINESS WIRE)--Endovasc, Inc. - (OTCBB: EVSC), a Business Development Company focused on acquiring and investing in companies engaged in the development of innovative cardiovascular and metabolic drugs, as well as nutraceutical supplements, is pleased to announce the appointment of Mr. Thomas Hall to its Board of Directors, effective November 28, 2006.
